Tara M Babu

Also affiliated with University of Washington

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial”.

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature Medicine(2023)10.1038/s41591-023-02503-4

N/A

1.3DataRank · unranked

56 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +94 more

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants

npj Vaccines(2023)10.1038/s41541-023-00693-z

N/A

1.1DataRank · unranked

33 citations

Robert L. Atmar, Clara Domínguez Islas, Christine M. Posavad, Meagan E. Deming, Angela R Branche +69 more

Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial

Research Square(2023)10.21203/rs.3.rs-2653179/v1

N/A

0.372DataRank · unranked

5 citations

Nadine Rouphael, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +63 more

Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf007

N/A

0.360DataRank · unranked

10 citations

Jasmine Ruffin, Ryan E. Wiegand, Craig B. Borkowf, Jade James-Gist, Tara M Babu +24 more

Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost

Nature Communications(2025)10.1038/s41467-025-55931-w

N/A

0.345DataRank · unranked

9 citations

Youyi Fong, Lauren Dang, Jonathan Fintzi, Shiyu Chen, Jing Wang +43 more

Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months–4 Years, United States, September 2022–April 2023

Journal of the Pediatric Infectious Diseases Society(2024)10.1093/jpids/piae121

N/A

0.292DataRank · unranked

6 citations

Jasmine Ruffin, Ryan E. Wiegand, Lauren Grant, Tara M Babu, Melissa Briggs‐Hagen +30 more

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf176

N/A

0.284DataRank · unranked

4 citations

Kirsten E. Lyke, Christine M. Posavad, Meagan E. Deming, Rebecca C. Brady, David Dobrzynski +32 more

Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial

Clinical Infectious Diseases(2024)10.1093/cid/ciae465

N/A

0.251DataRank · unranked

3 citations

Lauren Dang, Bo Zhang, Jonathan Fintzi, Shiyu Chen, Jing Wang +84 more

Health equity necessitates the inclusion of gender identity data in COVID-19 clinical trials

Annals of Epidemiology(2023)10.1016/j.annepidem.2023.06.024

N/A

0.165DataRank · unranked

2 citations

Anna Wald, Arjee Restar, Tara M Babu

Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial

medRxiv(2023)10.1101/2023.01.31.23285306

N/A

0.104DataRank · unranked

1 citations

Nadine Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer +31 more

Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial

Clinical Infectious Diseases(2023)10.1093/cid/ciad209

N/A

0DataRank · unranked

23 citations

Nadine Rouphael, Cecilia Losada, Lindsey R. Baden, Evan J. Anderson, Anne F. Luetkemeyer +31 more

Effect of Omicron BA.1-based compared to prototype booster mRNA vaccination on incidence of COVID-19 in the COVAIL trial

Vaccine(2025)10.1016/j.vaccine.2025.127718

N/A

0DataRank · unranked

0 citations

Daniel S. Graciaa, Bo Zhang, Nadine Rouphael, Angela R Branche, Thomas Martin +13 more

From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units

Clinical Infectious Diseases(2025)10.1093/cid/ciaf379

N/A

0DataRank · unranked

0 citations

Daniel S. Graciaa, Tara M Babu, Rhea N. Coler, Grant Paulsen, Daniel F. Hoft +5 more

Differentiating Mpox Infection and Vaccination Using a Validated Multiplex Orthopoxvirus IgG Serology Assay

medRxiv(2025)10.1101/2025.10.24.25338410

N/A

0DataRank · unranked

0 citations

Cecilia Downs, Kate McAllister, Clarice Mauer, Christopher L. McClurkan, Donna M. Wilson +8 more

Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

medRxiv(2023)10.1101/2023.06.06.23290973

N/A

0DataRank · unranked

0 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +31 more

Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine

Open Forum Infectious Diseases(2024)10.1093/ofid/ofad673

N/A

0DataRank · unranked

4 citations

Xiaoying Shen, R. Scott McClelland, Zijun Wang, Stacy Selke, Chloe Wilkens +11 more

Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial

The Journal of Infectious Diseases(2023)10.1093/infdis/jiad323

N/A

0DataRank · unranked

3 citations

Angela R Branche, David Diemert, Ann R. Falsey, Cecilia Losada, Lindsey R. Baden +80 more